Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonergic ergoline derivatives

S Mantegani1, E Brambilla, C Caccia

  • 1Pharmacia & Upjohn S.p.A.-CNS Research, Nerviano, Milan, Italy. sergio.mantegani@eu.pnu.com

Bioorganic & Medicinal Chemistry Letters
|January 1, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spontaneous urinary bladder rupture in a dog with lymphoplasmacytic cystitis.

The Journal of small animal practice·2025
Same author

Retraction Note: p14<sup>ARF</sup> promotes RB accumulation through inhibition of its Tip60-dependent acetylation.

Oncogene·2023
Same author

Microbial contamination of resin composites inside their dispensers: An increased risk of cross-infection?

Journal of dentistry·2021
Same author

Burden of COVID-19: Disability-Adjusted Life Years (DALYs) across 16 European countries.

European review for medical and pharmacological sciences·2021
Same author

Safety profile of Dupilumab during pregnancy: a data mining and disproportionality analysis of over 37,000 reports from the WHO individual case safety reporting database (VigiBase™).

European review for medical and pharmacological sciences·2021
Same author

L'emergenza COVID-19 nell'ottica del finanziamento del Servizio Sanitario Nazionale: analisi e proposte.

Igiene e sanita pubblica·2021
Same journal

Identification of TYK2 activators. Part 2: Optimization of terminal alkyne substituents to enhance activation potency.

Bioorganic & medicinal chemistry letters·2026
Same journal

Synthesis and biological investigation of phenothiazine-based derivatives as potential HDAC6 inhibitors for treatment of glioblastoma multiforme.

Bioorganic & medicinal chemistry letters·2026
Same journal

Solid-phase synthesis and antimicrobial activities of lipid-neomycin conjugates.

Bioorganic & medicinal chemistry letters·2026
Same journal

Discovery of a potent sGC stimulator with once-daily dosing potential for the treatment of hypertension.

Bioorganic & medicinal chemistry letters·2026
Same journal

OracleScreen-LILRB4 (HTS-Oracle v3): machine learning-guided discovery of myeloid immune checkpoint binders validated in patient-derived cells.

Bioorganic & medicinal chemistry letters·2026
Same journal

Rational design and N-terminal acylation of a lactam-cyclized 11-residue antimicrobial peptide for improved antibacterial potency.

Bioorganic & medicinal chemistry letters·2026
See all related articles

Researchers synthesized novel tert-butyl-ergoline derivatives to understand their binding affinities. The study highlights how tert-butyl group placement influences serotonin receptor interactions, specifically for 5-HT1A and 5-HT2 subtypes.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Neuroscience

Background:

  • Ergoline derivatives are known to interact with various neurotransmitter receptors.
  • Understanding structure-activity relationships is crucial for developing targeted therapeutics.

Purpose of the Study:

  • To synthesize and characterize novel 13- and 14-tert-butyl-ergoline derivatives.
  • To investigate the in vitro binding affinities of these compounds for adrenergic, dopaminergic, and serotonergic receptors.
  • To determine the impact of tert-butyl group presence and position on receptor affinity and selectivity, particularly for serotonin 5-HT1A and 5-HT2 receptors.

Main Methods:

  • Synthesis of novel tert-butyl-ergoline derivatives.
  • In vitro radioligand binding assays to assess receptor affinity.

Related Experiment Videos

  • Evaluation of selectivity for specific receptor subtypes (adrenergic, dopaminergic, serotonergic).

    • Main Results:

    • Novel classes of 13- and 14-tert-butyl-ergoline derivatives were successfully prepared.
    • The compounds exhibited varying affinities for adrenergic, dopaminergic, and serotonergic binding sites.
    • The presence and position of the tert-butyl group significantly influenced the affinity and selectivity for serotonin 5-HT1A and 5-HT2 receptors.

    Conclusions:

    • The tert-butyl group is a key structural feature modulating the pharmacological profile of ergoline derivatives.
    • Specific placement of the tert-butyl group can confer significant affinity and selectivity for serotonin 5-HT1A or 5-HT2 receptors.
    • These findings provide valuable insights for the design of novel ergoline-based ligands targeting serotonergic pathways.